“The spread of CP-CRE is a major public health concern because it is extremely drug resistant; however, the research on these pathogens is very limited, and so is our knowledge of their transmission,” said Vered Schechner, MD, lead author of the study published in Infection Control & Hospital Epidemiology. “Identifying high-risk groups helps us to avoid excessive screening that can be risky and expensive, and to determine who should be screened and who might be a candidate for pre-emptive isolation or antibiotics.”
Dr. Schechner and the team discovered that 96 percent of patient-to-patient transmission of CP-CRE had at least one of the following three risk factors:
- Contact for more than three days with an infected person
- Mechanical ventilation
- Infection with another multidrug-resistant bacteria
They also discovered patients who take cephalosporins were less likely to acquire CP-CRE than patients who took other types of antibiotics.
More articles on antibiotic resistance:
Antibiotic-resistant bacteria found in Florida wastewater following sewage spill
Despite major concerns about resistance, experts call on UN to widen global antibiotics access
Algorithm predicts effective treatments for drug-resistant fungal infections
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
